tirzepatide compound legal Eli Lilly just issued a public warning to the compounding industry. In a recent open letter, the pharmaceutical company raised concerns about products being combined with vitamin B12 and marketed in Compounded Tirzepatide: Legal & Safe

Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion

Still, these perceptions are not static and may shift as confidence in oral approaches grows

As a result, diabetes usually leads to an increase in the production of active radicals and a weakening of antioxidant defenses

Ozempic is a weekly injection for diabetes, and Wegovy is a higher-dose injection for weight loss

However, this approach carries the inherent risk of heightened side effects and drug toxicity